---
title: "September–October Will Reveal: Darnitsa Assesses the Risk of a Drug Shortage After Warehouse Strike"
description: "Kateryna Zagoriy, a member of Darnitsa's strategic council, explained to RBC-Ukraine that restoring stockpiles after the warehouse strike will take time, although a nationwide drug shortage has not yet been confirmed. September–October will be the key period for assessment."
date: 2026-09-18T08:10:01.000Z
lang: en
url: https://xab.info/en/posts/darnitsa-drug-shortage-risk-after-warehouse-strike
tags: [darnitsa, pharmaceuticals, medicine-shortage, supply-chain, ukraine, drug-prices]
publisher: "XAB.info"
---

# September–October Will Reveal: Darnitsa Assesses the Risk of a Drug Shortage After Warehouse Strike

![Pharmacist at a Darnytsia pharmacy handing medicines to a customer amid the risk of drug shortages after warehouse strikes](https://xab.info/media/2026/09/19/darnitsa-risk-deficita-lekarstv-posle-udara-po-skladam/darnitsa-risk-deficita-lekarstv-posle-udara-po-skladam-1.webp)

## 🎯 Key Points

- Restoring stockpiles after the strike on Darnitsa's warehouses takes time and is complicated by regular air-raid alerts
- It is premature to speak of a nationwide shortage: data on lost volumes, remaining stock at other facilities, and delivery timelines are needed
- Particular risk is posed by drugs with a limited number of suppliers, no analogues, or strict temperature requirements
- September–October will determine whether the losses are one-off or create systemic pressure on cost and prices

The destruction of pharmaceutical production warehousing capacity hits not only finished products but the entire supply chain — from re-manufacturing and quality control to final delivery to pharmacies. This was explained to RBC-Ukraine by Kateryna Zagoriy, a member of the strategic council of the pharmaceutical company Darnitsa and co-founder of the Zagoriy Foundation. According to her, restoring stockpiles takes time, and under conditions of regular air-raid alerts and repeated attacks, this process is further complicated.

### Why It Is Premature to Speak of a Nationwide Shortage

Zagoriy emphasizes that it would be incorrect to assess the situation as a nationwide drug shortage based solely on the destruction of individual warehouses. An objective assessment requires understanding the lost volumes, the remaining stock at other facilities, and the timelines for subsequent deliveries. It is only possible to say whether reserves are sufficient for uninterrupted patient supply once there is an up-to-date picture across specific drug groups and supply chains.### Drugs Under Special Watch

Particular attention, Zagoriy says, should be paid to those medicines where the possibility of rapid substitution is limited. This refers to drugs with a small number of suppliers, without full analogues, or with strict temperature-regime requirements. It is precisely for such items that local disruptions could potentially be most noticeable for patients.

### Impact on Cost and Prices

At the first stage, the additional costs effectively fall on the business: companies have to hold larger safety stocks, disperse them, and duplicate logistics. If such scenarios repeat, military risks become a permanent component of the cost base and can create pressure on the final price. At the same time, Zagoriy notes that it is important to distinguish between the manufacturer and the pharmacy chain, since the final price depends not only on the producer but also on the chain's own pricing policy. September–October will allow a better assessment of whether the current losses are one-off or will begin to create systemic pressure on the availability and cost of medicines.

### What Is Reasonable for Patients to Do

Under current conditions, Zagoriy believes that having a home medicine cabinet and a stock of the prescribed amount of medicines is a sensible measure, especially if the drugs are taken regularly and a break in treatment is unsafe for health. The expert does not call for panic buying but recommends taking individual therapy specifics into account and not interrupting a course without consulting a doctor.

## 🔍 Fact-Check Verification

- [September–October Will Reveal. How Darnitsa Assesses the Risk of a Drug Shortage and What Will Happen to Prices](https://www.rbc.ua/ukr/news/veresen-zhovten-pokazhut-k-darnitsi-otsinyuyut-1789718807.html) - Первичный источник комментария Екатерины Загорий. Все цитаты и тезисы статьи соответствуют тексту интервью.
- [Russian Strike on Darnitsa Pharma Plant: The Scale of Damage and Whether There Will Be a Drug Shortage](https://delo.ua/ru/news/udar-rf-po-farmzavodu-darnica-kakaya-summa-ushherba-i-budet-li-deficit-lekarstv-468353/) - Подтверждает факт удара по производственным мощностям и контекст оценки ущерба.
- [Should You Buy Up Medicines: Darnitsa Responds After the Russian Strike on Whether There Will Be a Shortage](https://www.obozrevatel.com/ekonomika-glavnaya/economy/stoit-li-skupat-lekarstva-posle-udara-po-darnitse-v-kompanii-otvetili-budet-li-defitsit-populyarnyih-preparatov.htm) - Совпадает по ключевым тезисам: отсутствие паники, акцент на конкретных группах препаратов.
- [Will There Be a Drug Shortage After the Strike on Darnitsa: The Manufacturer's Answer](https://focus.ua/economics/759455-budet-li-deficit-lekarstv-posle-udara-po-darnice-otvet-proizvoditelya) - Дополнительное подтверждение позиции компании: разовый характер потерь пока не исключает системных последствий.

## ❓ FAQ

### Q: Will there be a nationwide drug shortage after the strike on Darnitsa's warehouses?
**A:** According to Kateryna Zagoriy, it is incorrect to assess the situation as a nationwide shortage based solely on the destruction of individual warehouses. This requires data on lost volumes, remaining stock at other facilities, and the timelines for subsequent deliveries.

### Q: Which drugs are in the highest risk group?
**A:** Particular attention is paid to medicines with a small number of suppliers, without full analogues, or with strict temperature-regime requirements. It is precisely for such items that local disruptions could be most noticeable.

### Q: Will medicines become more expensive?
**A:** At the first stage, the additional costs fall on the business. If the scenarios repeat, military risks become a permanent component of the cost base and can create pressure on prices. September–October will allow an assessment of whether the losses are one-off or systemic.

### Q: Should I buy medicines in advance now?
**A:** Zagoriy does not call for panic buying but considers it reasonable to have a home medicine cabinet and a stock of the prescribed amount of medicines, especially if the drugs are taken regularly and a break in treatment is unsafe for health.